| __timestamp | Regeneron Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 5280000 |
| Thursday, January 1, 2015 | 1620577000 | 7148000 |
| Friday, January 1, 2016 | 2052295000 | 19594000 |
| Sunday, January 1, 2017 | 2075142000 | 22894000 |
| Monday, January 1, 2018 | 2186100000 | 50337000 |
| Tuesday, January 1, 2019 | 3036600000 | 109450000 |
| Wednesday, January 1, 2020 | 2735000000 | 90450000 |
| Friday, January 1, 2021 | 2908100000 | 104128000 |
| Saturday, January 1, 2022 | 3592500000 | 108630000 |
| Sunday, January 1, 2023 | 4439000000 | 134951000 |
| Monday, January 1, 2024 | 5132000000 |
Unleashing the power of data
In the ever-evolving world of pharmaceuticals, innovation is key to staying ahead. Regeneron Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. exemplify this through their research and development (R&D) spending. Over the past decade, Regeneron has consistently prioritized innovation, with R&D expenses growing by approximately 250% from 2014 to 2023. In contrast, Rhythm Pharmaceuticals, while smaller in scale, has shown a remarkable increase of over 2,400% in the same period, reflecting its commitment to innovation despite its size.
Regeneron's R&D spending surged from $1.3 billion in 2014 to $4.4 billion in 2023, highlighting its robust investment in new drug development. Meanwhile, Rhythm's R&D expenses, though starting at a modest $5.3 million in 2014, reached $135 million by 2023. This growth underscores the dynamic nature of the pharmaceutical industry and the critical role of R&D in driving future success.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. or argenx SE: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Galapagos NV
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for GSK plc and Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Genmab A/S vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds